SCHEMBL18200364

SCHEMBL18200364

c1ccc2c(c1)ccc1cc(-c3ccc(-c4nc5ccccc5c5c4ccc4ccccc45)cc3)ccc12

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.40
ALDH1A1 P00352 2/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
LMNA P02545 2/20 0.40
GAA P10253 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
HIF1A Q16665 1/20 0.40
CYP1B1 Q16678 1/20 0.40
HSD17B10 Q99714 1/20 0.40
DHODH Q02127 3/20 0.39
ADORA2A P29274 3/20 0.39
NUDT1 P36639 1/20 0.39
HPRT1 P00492 1/20 0.38
PDE10A Q9Y233 1/20 0.38
PIK3CD O00329 1/20 0.38
PIK3CA P42336 1/20 0.38
PIK3CB P42338 1/20 0.38
MTOR P42345 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18200519 1.00 KDM4E (0.40) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL18200604 0.94 ESR1 (0.42) KDM4EALDH1A1MEN1KMT2ADHODH
SCHEMBL18201033 0.94 ESR1 (0.42) KDM4EALDH1A1MEN1KMT2ADHODH
SCHEMBL18200538 0.94 ESR1 (0.42) KDM4EALDH1A1MEN1KMT2ADHODH
SCHEMBL18201075 0.94 ALDH1A1 (0.42) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL18200400 0.93 MAPK8 (0.40) KDM4EALDH1A1LMNAGAAHIF1A
SCHEMBL18200599 0.91 NUDT1 (0.42) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL17034891 0.91 DHODH (0.39) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL18200601 0.91 NUDT1 (0.47) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL18200600 0.91 NUDT1 (0.47) KDM4EALDH1A1MEN1KMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-9728731-B2 Heterocyclic compound and organic light emitting device using same HEESUNG MATERIAL LTD. (KR) 2017-08-08 US disclosed
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME HEESUNG MATERIAL LTD. (KR) 2016-12-29 US disclosed
EP-3088392-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME Heesung Material Ltd. (KR) 2016-11-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160380208-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME NOTUM, DDT, CRY1 KDM4E 1977/4885ALDH1A1 85/4885MEN1 1750/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.